+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale

Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale

Clinical and Experimental Immunology 105(1): 79-83

We have previously reported the finding of circulating antibodies recognizing two proteins of 100 and 120 kD (PO100 and PO120) from Pityrosporum ovale in patients with psoriasis. These antibodies were specific, since they were not detected in normal sera nor in other diseases linked to P. ovale such as seborrhoeic dermatitis or pityriasis versicolor. The present study aimed at further characterizing the specificity of these antibodies. Enzyme-labelled lectins were used to determine the carbohydrate composition of PO120 and PO100. BSII, a lectin that recognizes terminal N-acetylglucosamine (GlcNAc), showed the same banding pattern as sera from patients. Reactivity against these proteins was inhibited after mild oxidation of the carbohydrate moieties of the extract. Treatment of the extracts with lyticase altered the immune reactivity against the PO120 band as seen in Western blot assays. PO100 was not detected after lyticase digestion. Digestion with lysozyme did not alter the immune reactivity of the PO100 and PO120 bands, although the protein pattern in SDS-PAGE was modified. To examine the relevance of anti-GlcNAc antibodies in the immune response to P. ovale in psoriasis, we performed a binding inhibition ELISA. Psoriatic sera that were positive in the ELISA against a heat-denatured extract of P. ovale were rendered negative only by pre-incubation with GlcNAc in a concentration-dependent manner. Our results are indicative that the antibody response to PO100 and PO120 in patients with psoriasis is directed towards terminal GlcNAc residues.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 008169767

Download citation: RISBibTeXText

PMID: 8697640

DOI: 10.1046/j.1365-2249.1996.d01-719.x

Related references

Sera from patients with psoriasis recognize N-acetyl-glucosamine residues in Pityrosporum ovale extracts. Journal of Investigative Dermatology 102(4): 637, 1994

Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clinical and Experimental Dermatology 19(4): 289-293, 1994

A 120 kD soluble protein from Pityrosporum ovale is recognized by sera from patients with psoriasis. Journal of Investigative Dermatology 100(4): 576, 1993

Does pityrosporum ovale have a role in psoriasis?. Archives of Dermatology 126(8): 1111-1112, 1990

IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clinical and Experimental Allergy 27(1): 87-95, 1997

Role of Pityrosporum ovale in guttate psoriasis. Journal of Dermatology 30(3): 252-254, 2003

The evaluation of various methods and antigens for the detection of antibodies against Pityrosporum ovale in patients with seborrhoeic dermatitis. Clinical and Experimental Dermatology 16(5): 339-343, 1991

Effect of bimolane on the pityrosporum ovale rabbit psoriasis model. Clinical Pharmacology and Therapeutics 41(2): 199, 1987

Cladosporium herbarum and Pityrosporum ovale allergen extracts share cross-reacting glycoproteins. International Archives of Allergy and Immunology 140(1): 30-35, 2006

Properdin deposition in psoriasis lesions induced by Malassezia ovalis (Pityrosporum ovale). Clinical Research 30(2): 575A, 1982

IgE antibodies to Pityrosporum ovale in atopic dermatitis. British Journal of Dermatology 125(3): 227-232, 1991